The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis

NCT03340649 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2017-11-13

No results posted yet for this study

Summary

To observe the changes of plasma hepatocyte growth factor and soluble receptor s-Met levels in patients with sepsis, and to explore its clinical significance.

Conditions

Interventions

OTHER

taking peripheral blood

taking peripheral blood of no more than 3ml

Sponsors & Collaborators

  • Jingyuan,Xu

    lead OTHER

Principal Investigators

  • yi yang, doctor · Zhongda Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-09
Primary Completion
2017-11-09
Completion
2018-03-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340649 on ClinicalTrials.gov